ARDX
ARDX
NASDAQ · Biotechnology

Ardelyx Inc

$5.64
+0.29 (+5.42%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +735.8% upside
Low Target $33.22
Average Target $47.14
High Target $55.45
Current Price $5.64
Current
$5.64
Target
$47.14
$33.22 $47.14 avg $55.45
Scenario Analysis
Bear Case
$33.22
489.0%
Low target
Base Case
$47.14
+735.8%
Avg target
Bull Case
$55.45
+883.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$8.40
-32.9% from high
52-Week Low
$3.21
+75.7% from low
Target vs 52W High
$47.14
+461.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%